MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease
MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease
复制标题
DOI:
10.1038/mi.2015.96
复制
发表时间:
2015-10
影响因子:
8
通讯作者:
Ji-Young Lim;Young Kwan Lee;S. Lee;J. Ju;K. Eom;Yun Ju Kim;Nak-Gyun Chung;Dae-Chul Jeong;G. Park;Choi Ey;Chang-Ki Min
中科院分区:
文献类型:
--
作者:
Ji-Young Lim;Young Kwan Lee;S. Lee;J. Ju;K. Eom;Yun Ju Kim;Nak-Gyun Chung;Dae-Chul Jeong;G. Park;Choi Ey;Chang-Ki Min
To understand the role of myeloid differentiation factor 88 (MyD88) expressed by donor bone marrow (BM) in the pathophysiology of graft-vs.-host disease (GVHD), we investigated the effects of transplantation of MyD88-deficient T cell-depleted BM (MyD88KO TCD-BM) on the severity of GVHD. Transplantation with MyD88KO TCD-BM aggravated GVHD; serious gut damage was evident, with high infiltration of T cells into the intestines of recipients and markedly reduced expansion of CD11b+ Gr-1+ myeloid-derived suppressor cells (MDSCs). MDSCs from MyD88KO mice were defective in inducing donor T-cell apoptosis and inhibiting T-cell proliferation. Supplementation of transplanted mice with MDSCs from wild-type mice, but not MyD88KO mice, attenuated GVHD severity with reduced intestinal T-cell infiltration in MyD88KO TCD-BM recipients. Pretreatment of BM donors with lipopolysaccharide to increase MDSC levels and MyD88 transcription in the TCD-BM transplant alleviated GVHD severity and intestinal T-cell infiltration. The T cell/MDSC ratios were correlated with intestinal GVHD severity in both animal models and human patients. This study indicates that MyD88-dependent MDSC expansion from donor BM is critical for protection against fatal intestinal GVHD.